[1. FATOURECHI V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009; 84(1):65-71.10.4065/84.1.65]Search in Google Scholar
[2. WIERSINGA WM. Guidance in subclinical hyperthyroidism and subclinical hypothyroidism: are we making progress? Eur Thyroid J. 2015; 4(3):143-8.10.1159/000438909463750926558231]Search in Google Scholar
[3. MALEKI N., KAZEROUNI F., HEDAYATI M., RAHIMIPOUR A., PARHAM M. Subclinical hypothyroidism and the alterations of lipid profile as a cardiovascular risk factor. J Paramed Sci. 2015; 6(4):2008-4978.]Search in Google Scholar
[4. RIZOS CV., ELISAF MS., LIBEROPOULUS EN. Effects of thyroid dysfunction on lipid profile, Open Cardiovasc Med J. 2011; 5:76-84.]Search in Google Scholar
[5. VANDERMEERSCH A., AMEYE S., PUYPE D., PETITJEAN D., De BUYZERE M., LANGLOIS MR. Estimation of the lowdensity lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment. Clin Chim Acta. 2010; 411(17-18):1361-66.10.1016/j.cca.2010.05.03820561981]Search in Google Scholar
[6. NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS (Adult Treatment Panel III), Third report of the National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002; 106(25):3143-3421.10.1161/circ.106.25.3143]Search in Google Scholar
[7. AUSTIN MA., BRESLOW JL., HENNEKENS CH., BURING JE., WILLETT WC., KRAUSS RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988; 260(13):1917-21.10.1001/jama.1988.03410130125037]Search in Google Scholar
[8. CARMENA R., DURIEZ P., FRUCHART JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004; 109 (23 Suppl 1):III2-7.10.1161/01.CIR.0000131511.50734.4415198959]Search in Google Scholar
[9. BERNEIS KK., KRAUSSS RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002; 43(9):1363-79.10.1194/jlr.R200004-JLR20012235168]Search in Google Scholar
[10. LAMARCHE B., TCHERNOF A., MOORJANI S., CANTIN B., DAGENAIS GR., LUPIEN PJ., et al. Small, dense LDL particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997; 95(1):69-75.10.1161/01.CIR.95.1.698994419]Search in Google Scholar
[11. VERHOYE E., LANGLOIS MR., ASKLEPIOS INVESTIGATORS. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med. 2009; 47(2):128-37.10.1515/CCLM.2009.03719099526]Search in Google Scholar
[12. TOGNINI S., POLINI A., PASAQUALETTI G., URSINO S., CARACCIO N., ERDEGHINI M., et al. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Thyroid. 2012; 22(11):1096-103.10.1089/thy.2012.001323050788]Search in Google Scholar
[13. HAK AE., POLS HA., VISSER TJ., DREXHAGE HA., HOFMAN A., WITTEMAN JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000; 132(4):270-8.10.7326/0003-4819-132-4-200002150-0000410681281]Search in Google Scholar
[14. WALSH JP., BREMNER AP., BULSARA MK., O’LEARY P., LEEDMAN PJ., FEDDEMA P., et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005; 165(21):2467-72.10.1001/archinte.165.21.246716314542]Search in Google Scholar
[15. COOPER DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001; 345(4):260-5.10.1056/NEJM20010726345040611474665]Search in Google Scholar
[16. KLEIN I. Subclinical hypothyroidism - just a high serum thyrotropin concentration or something else? J Clin Endocrinol Metab. 2013; 98(2):508-10.10.1210/jc.2012-408823390261]Search in Google Scholar
[17. DUNTAS LH., BRENTA G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 2012; 96(2):269-81.10.1016/j.mcna.2012.01.01222443975]Search in Google Scholar
[18. PEARCE EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab. 2012; 97(2):326-33.10.1210/jc.2011-253222205712]Search in Google Scholar
[19. BOEKHOLDT SM., TITAN SM., WIERSINGA WM., CHATTERJEE K., BASART DC., LUBEN R., et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010; 72(3):404-10.10.1111/j.1365-2265.2009.03640.x19486022]Search in Google Scholar
[20. WORLD HEALTH ORGANIZATION. “BMI Classification”. Global Database on Body Mass Index. 2006.]Search in Google Scholar
[21. KUSIC Z., JUKIC T., FRANCESCHI M., DEBELIC N., RONCEVIC S., LUKINAC L. Croatian Thyroid Society guidelines for rational detection of thyroid dysfunction. Lijec Vjesn. 2009; 131(11-12):328-38.]Search in Google Scholar
[22. LUBOSHITZKY R., AVIV A., HERER P., LAVIE L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2002; 12(5):421-5.10.1089/10507250276004351212097204]Search in Google Scholar
[23. KARTHICK N., DILLARA K., POORNIMA KN., SBHASINI AS. Dyslipidaemic changes in women with subclinical hypothyroidism. J Clin Diagn Res. 2013; 7(10):2122-5.10.7860/JCDR/2013/5777.3448384338924298454]Search in Google Scholar
[24. TOURNER F., ALTINOVA AE., KARAKOC A., YETKIN I., AYVAZ G., CAKIR N., et al. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther. 2008; 25(5):430-7.10.1007/s12325-008-0053-718484201]Search in Google Scholar
[25. PEARCE SH., BRABANT G., DUNTAS LH., MONZANI F., PEETERS RP., RAZVI S., et al. 2013 ETA Guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013; 2(4):215-28.10.1159/000356507392360124783053]Search in Google Scholar
[26. ABBAS JM., CHAKRABORTY J., AKANJI AO., DOI SA. Hypothyroidism results in small dense LDL independent of IRS traits and hypertriglyceridemia. Endocr J. 2008; 55(2):381-9.10.1507/endocrj.K07E-06518385530]Search in Google Scholar
[27. RAZVI S., WEAVER JU., VANDERPUMP MP, PEARCE SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: re-analysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010; 95:1734-40.10.1210/jc.2009-174920150579]Search in Google Scholar
[28. CAPPOLA AR., FRIED LP., ARNOLD AM., DANESE MD., KULLER LH., BURKE GL., et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 295(9):1033-41.10.1001/jama.295.9.1033138782216507804]Search in Google Scholar
[29. LAM KS., CHAN MK., YEUNG RT. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction-effects of treatment. Q J Med. 1986; 59(229):513-521.]Search in Google Scholar
[30. PEARCE EN., WILSON PW., YANG Q., VASAN RS., BRAVERMAN LE. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab. 2008; 93(3):888-94.10.1210/jc.2007-1987226694618073305]Search in Google Scholar